High MCHC Symptoms: Causes, Signs & What to Do
High MCHC means red blood cells are abnormally dense with hemoglobin -- the hallmark finding of hereditary spherocytosis, the most common inherited hemolytic anemia. This page covers the specific symptoms, likely causes, normal ranges, and when to act.
MCHC (mean corpuscular hemoglobin concentration) measures how concentrated the hemoglobin is inside each red blood cell — the grams of hemoglobin per deciliter of packed red cells. High MCHC (above 36-37 g/dL) means red blood cells are abnormally dense. Unlike most CBC indices, a significantly elevated MCHC almost always points to a specific clinically meaningful condition — most commonly hereditary spherocytosis — rather than a benign lab variation. See the MCHC biomarker overview for how it is calculated and how it relates to MCH and MCV.
What High MCHC Means
Red blood cells normally have a biconcave disc shape with a pale center on blood smear, representing areas where the cell is thin and hemoglobin is less concentrated. Spherocytes are small, round, uniformly stained cells with no central pallor — all the hemoglobin is packed throughout. This uniform filling raises the MCHC. The three meaningful causes of a truly elevated MCHC are:
- Hereditary spherocytosis — genetic defects in red cell membrane scaffold proteins (spectrin, ankyrin, band 3) cause the membrane to shed lipid vesicles, producing progressively smaller and denser cells
- Autoimmune hemolytic anemia — IgG or IgM antibodies coat red cells and trigger splenic macrophages to remove membrane fragments, converting normal cells into spherocytes
- Cold agglutinins — IgM antibodies that clump red cells at cool temperatures; cell aggregation on the blood counter falsely raises the measured hemoglobin concentration
Artifactual MCHC elevation also occurs in lipemic (turbid) or hemolyzed samples — the lab will typically flag these.
Symptoms of High MCHC
Most symptoms arise from the underlying hemolytic process rather than the MCHC elevation itself.
Hereditary spherocytosis:
- Anemia symptoms: fatigue, pallor, shortness of breath on exertion, palpitations
- Jaundice — yellow discoloration of the skin and sclerae from elevated unconjugated bilirubin (hemoglobin breakdown product); intermittent or chronic
- Splenomegaly — the spleen enlarges as it filters and destroys increasing numbers of spherocytes; left-sided abdominal fullness or discomfort
- Pigment gallstones — chronic bilirubin overproduction leads to bilirubin-calcium gallstone formation; presents as biliary colic or cholecystitis
- Aplastic crises — parvovirus B19 infection temporarily suppresses red cell production; in spherocytosis (where red cell lifespan is already short), this can cause rapid severe anemia requiring transfusion
- In mild cases: may be entirely asymptomatic; discovered incidentally or during family screening
What Causes High MCHC
- Hereditary spherocytosis (HS) — the most common inherited hemolytic anemia in Northern European populations (1 in 2,000); autosomal dominant in 75% of cases; mutations in genes encoding red cell membrane proteins (SPTA1, SPTB, ANK1, SLC4A1, EPB42)
- Autoimmune hemolytic anemia (AIHA) — warm AIHA (IgG antibodies active at body temperature) is most common; associated with CLL, lupus, infections, medications; cold AIHA (IgM + complement) is associated with Mycoplasma infection and lymphoma
- Sickle cell disease (HbSS) — sickle cells become dense and dehydrated when deoxygenated; MCHC rises in dehydrated sickle cells
- Artifactual: lipemia, severe hemolysis in the sample tube, cold agglutinins causing cell aggregation at room temperature — always interpret with lab QC flags
Normal MCHC Levels
| Category | MCHC (g/dL) | |---|---| | Normal (adults) | 32-36 g/dL | | High MCHC | Above 36-37 g/dL | | Clinically significant elevation | Above 38 g/dL |
MCHC should be interpreted alongside the blood smear — the presence of spherocytes, hypersegmented neutrophils, or target cells narrows the differential immediately.
When to See Your Care Team
Book a 1:1 consultation with a licensed care team lead for MCHC above 36 g/dL on repeat testing with a non-lipemic, non-hemolyzed sample. The essential next steps are a peripheral blood smear (looking for spherocytes), direct antiglobulin test (DAT/Coombs — to distinguish HS from AIHA), reticulocyte count, and bilirubin. If hereditary spherocytosis is suspected, osmotic fragility testing and eosin-5-maleimide (EMA) flow cytometry confirm the diagnosis.
Frequently Asked Questions
How is hereditary spherocytosis different from autoimmune hemolytic anemia?
Both produce spherocytes and elevated MCHC. The direct antiglobulin test (DAT/Coombs test) distinguishes them: DAT is negative in hereditary spherocytosis (no antibody coating the cells) and positive in autoimmune hemolytic anemia (antibody or complement on cell surface). Family history of hemolytic anemia or gallstones in a young person also strongly suggests HS.
Can hereditary spherocytosis be mild?
Yes. Hereditary spherocytosis ranges from very mild (compensated hemolysis with normal hemoglobin, only slightly elevated reticulocytes and bilirubin) to severe (transfusion-dependent). Many people are not diagnosed until adulthood, either incidentally or when they develop gallstones. The severity correlates roughly with the severity of the underlying membrane protein defect.
Does splenectomy cure hereditary spherocytosis?
Splenectomy eliminates the primary site of spherocyte destruction and resolves the anemia in the vast majority of patients — hemoglobin normalizes, jaundice resolves, and gallstone formation stops. However, the spherocytes themselves persist (the membrane defect is unchanged). Splenectomy is generally recommended for moderate-to-severe HS with significant anemia, growth impairment, or recurrent aplastic crises. Vaccinations (pneumococcal, meningococcal, Haemophilus influenzae type B) are essential before splenectomy.
What is a cold agglutinin and why does it cause high MCHC?
Cold agglutinins are IgM antibodies that bind red blood cell antigens and clump cells together at temperatures below body temperature (typically 4-22 degrees C). When blood is processed in a laboratory at room temperature, the cold agglutinins cause red cells to aggregate. The automated cell counter interprets the clusters as fewer, larger cells, and calculates an artificially high MCHC. Warming the sample to 37 degrees C before reanalysis resolves the artifact and reveals the true MCHC.
